Literature DB >> 18628735

What is the potential role of antifibrotic agents for the treatment of liver disease?

Bernd Schnabl1, David Scholten, David A Brenner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18628735     DOI： 10.1038/ncpgasthep1200

Source DB:  PubMed          Journal:  Nat Clin Pract Gastroenterol Hepatol        ISSN： 1743-4378


× No keyword cloud information.
  8 in total

1.  Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice.

Authors:  Magdalena Mazagova; Lirui Wang; Andrew T Anfora; Max Wissmueller; Scott A Lesley; Yukiko Miyamoto; Lars Eckmann; Suraj Dhungana; Wimal Pathmasiri; Susan Sumner; Caroline Westwater; David A Brenner; Bernd Schnabl
Journal:  FASEB J       Date:  2014-12-02       Impact factor: 5.191

Review 2.  Gut microbiota in liver disease: too much is harmful, nothing at all is not helpful either.

Authors:  Phillipp Hartmann; Huikuan Chu; Yi Duan; Bernd Schnabl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-02-15       Impact factor: 4.052

3.  CXCL5 plasma levels decrease in patients with chronic liver disease.

Authors:  Frank Tacke; Henning W Zimmermann; Christian Trautwein; Bernd Schnabl
Journal:  J Gastroenterol Hepatol       Date:  2011-03       Impact factor: 4.029

4.  Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease.

Authors:  Derrick E Fouts; Manolito Torralba; Karen E Nelson; David A Brenner; Bernd Schnabl
Journal:  J Hepatol       Date:  2012-02-09       Impact factor: 25.083

Review 5.  What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis.

Authors:  Keiko Iwaisako; David A Brenner; Tatiana Kisseleva
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

Review 6.  Molecular pathogenesis of liver fibrosis.

Authors:  David A Brenner
Journal:  Trans Am Clin Climatol Assoc       Date:  2009

7.  Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist.

Authors:  Keiko Iwaisako; Michael Haimerl; Yong-Han Paik; Kojiro Taura; Yuzo Kodama; Claude Sirlin; Elizabeth Yu; Ruth T Yu; Michael Downes; Ronald M Evans; David A Brenner; Bernd Schnabl
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-25       Impact factor: 11.205

8.  Chronic restraint stress decreases the repair potential from mesenchymal stem cells on liver injury by inhibiting TGF-β1 generation.

Authors:  X Yang; Z-P Han; S-S Zhang; P-X Zhu; C Hao; T-T Fan; Y Yang; L Li; Y-F Shi; L-X Wei
Journal:  Cell Death Dis       Date:  2014-06-26       Impact factor: 8.469
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.